ENANTA PHARMACEUTICALS INC financial data

Symbol
ENTA on Nasdaq
Location
Watertown, MA
Fiscal year end
30 September
Latest financial report
10-K - Q3 2025 - 19 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 499% % -13%
Debt-to-equity 259% % 68%
Return On Equity -94% % -28%
Return On Assets -26% % 8.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28,862,601 shares 36%
Common Stock, Shares, Outstanding 21,387,000 shares 0.91%
Entity Public Float $110,592,792 USD -68%
Common Stock, Value, Issued $214,000 USD 0.94%
Weighted Average Number of Shares Outstanding, Basic 21,336,000 shares 0.85%
Weighted Average Number of Shares Outstanding, Diluted 21,336,000 shares 0.85%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $65,324,000 USD -3.4%
Research and Development Expense $106,740,000 USD -19%
General and Administrative Expense $43,933,000 USD -24%
Costs and Expenses $150,673,000 USD -20%
Operating Income (Loss) $85,349,000 USD 30%
Nonoperating Income (Expense) $1,800,000 USD -54%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $83,549,000 USD 29%
Income Tax Expense (Benefit) $1,660,000 USD 4.8%
Net Income (Loss) Attributable to Parent $81,889,000 USD 29%
Earnings Per Share, Basic -3 USD/shares 30%
Earnings Per Share, Diluted -3 USD/shares 30%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $32,298,000 USD -13%
Accounts Receivable, after Allowance for Credit Loss, Current $6,882,000 USD 3.6%
Assets, Current $204,336,000 USD -32%
Property, Plant and Equipment, Net $35,395,000 USD 8.3%
Operating Lease, Right-of-Use Asset $37,549,000 USD -7.6%
Other Assets, Noncurrent $92,000 USD -2.1%
Assets $280,732,000 USD -25%
Accounts Payable, Current $1,948,000 USD -76%
Employee-related Liabilities, Current $6,469,000 USD -1.5%
Accrued Liabilities, Current $12,751,000 USD -5.9%
Liabilities, Current $48,555,000 USD -16%
Operating Lease, Liability, Noncurrent $54,757,000 USD 1.5%
Other Liabilities, Noncurrent $260,000 USD 13%
Liabilities $216,015,000 USD -13%
Accumulated Other Comprehensive Income (Loss), Net of Tax $339,000 USD -212%
Retained Earnings (Accumulated Deficit) $404,929,000 USD -25%
Stockholders' Equity Attributable to Parent $64,717,000 USD -50%
Liabilities and Equity $280,732,000 USD -25%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $16,801,000 USD 33%
Net Cash Provided by (Used in) Financing Activities $4,986,000 USD 32%
Net Cash Provided by (Used in) Investing Activities $68,903,000 USD
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 21,387,000 shares 0.91%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $47,116,000 USD
Interest Paid, Excluding Capitalized Interest, Operating Activities $3,008,000 USD -4.3%
Deferred Tax Assets, Valuation Allowance $142,233,000 USD 12%
Deferred Tax Assets, Gross $154,217,000 USD 9.1%
Operating Lease, Liability $57,903,000 USD 4.4%
Payments to Acquire Property, Plant, and Equipment $8,745,000 USD 1011%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $82,530,000 USD 28%
Lessee, Operating Lease, Liability, to be Paid $86,018,000 USD -9.2%
Property, Plant and Equipment, Gross $59,200,000 USD 2.5%
Operating Lease, Liability, Current $3,146,000 USD 106%
Lessee, Operating Lease, Liability, to be Paid, Year Two $8,721,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $8,467,000 USD -2.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $27,785,000 USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year Three $8,983,000 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $14,782,000 USD 103%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $892,000 USD -1.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four $9,252,000 USD 3%
Deferred Tax Assets, Net of Valuation Allowance $11,984,000 USD -15%
Share-based Payment Arrangement, Expense $18,565,000 USD -31%
Interest Expense $2,355,000 USD 18%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%